Investing Ideas
/
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

214

9 new

Companies with a Value score of at least 3, ordered by Value score

214 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
0O9B Almirall	€9.10	0.03%	10.1%	€1.9b	€11.80	PS2x	E45.5%	2.0%
0O1O Vetoquinol	€73.30	-0.4%	-26.8%	€866.1m	€93.56	PE18.4x	E7.5%	1.2%
0Q1N Pfizer	US$26.10	1.8%	-6.8%	US$146.8b	US$31.42	PE18.3x	E3.6%	6.6%
0ILL Laboratorios Farmaceuticos Rovi	€54.85	1.0%	-23.4%	€2.8b	€78.58	PE17x	E13.4%	2.0%
0O14 Merck KGaA	€135.55	-0.4%	-14.7%	€58.9b	€180.82	PE21.9x	E10.2%	1.6%
0QAH Merck	US$88.70	6.1%	-31.5%	US$221.8b	US$115.38	PE13x	E7.6%	3.7%
0NM7 Virbac	€311.00	-1.7%	-9.9%	€2.6b	€396.31	PE18.5x	E10.4%	0.4%
INDV Indivior	UK£6.89	-12.8%	-59.2%	UK£855.6m	UK£12.24	PS0.9x	E48.7%	0%
INDVL Indivior	UK£7.29	-7.2%	-56.9%	UK£855.6m	UK£12.95	PS0.9x	E48.7%	0%
0LER Teva Pharmaceutical Industries	US$17.23	5.8%	35.7%	US$19.5b	US$24.21	PS1.2x	E66.6%	0%
0J2O Halozyme Therapeutics	US$57.93	-0.9%	42.6%	US$7.1b	US$66.67	PE15.9x	E15.4%	n/a
0QCO Pharming Group	€0.87	1.6%	-17.0%	€593.6m	€1.83	PS2.2x	E57.2%	n/a
0QLR Novartis	CHF 97.70	1.3%	6.6%	CHF 193.9b	CHF 101.64	PE18.1x	E7.0%	3.5%
GSK GSK	UK£14.29	-0.4%	-14.6%	UK£58.3b	UK£17.97	PE22.6x	E18.0%	4.3%
0K6R Neurocrine Biosciences	US$120.33	4.2%	-10.4%	US$11.6b	US$172.50	PE33.9x	E27.2%	n/a
0A5V Viatris	US$11.75	8.1%	-12.7%	US$13.2b	US$14.03	PS0.9x	E52.4%	4.3%
NOVNz Novartis	CHF 96.75	1.5%	5.7%	CHF 193.9b	CHF 100.65	PE18.1x	E7.0%	3.5%
COPNZ Cosmo Pharmaceuticals	CHF 66.50	3.6%	1.4%	CHF 1.1b	CHF 95.92	PE16.7x	E21.5%	2.8%
APH Alliance Pharma	UK£0.61	-1.1%	35.9%	UK£328.7m	UK£0.66	PS1.8x	E67.0%	0%
0P6S Bayer	€22.08	2.6%	-23.4%	€21.7b	€27.55	PS0.5x	E44.9%	0.5%
0HF9 Amicus Therapeutics	US$9.06	-6.9%	-32.8%	US$2.7b	US$16.79	PS5.2x	E53.9%	n/a
0JDM IQVIA Holdings	US$192.79	-2.2%	-21.8%	US$34.2b	US$246.04	PE24.9x	E14.4%	0%
BXP New Beximco Pharmaceuticals	UK£0.39	0%	-4.9%	UK£34.2b	UK£0.78	PE5.4x	E16.5%	5.2%
GSKL GSK	UK£14.47	1.0%	-13.5%	UK£58.3b	UK£18.19	PE22.6x	E18.0%	4.3%

Page 1 of 9